Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-12

Clinical Trial Update: Losartan Versus Atenolol for the Treatment of Marfan Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial comparing losartan to atenolol for Marfan syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cozaar (losartan)
  • TENORMIN (ATENOLOL)

Snippet

Sponsor: University of British Columbia | Conditions: Marfan Syndrome | Phase 2 | Status: COMPLETED